Biostem Technologies Inc (BSEM)

Currency in USD
11.2621
-0.6979(-5.84%)
Closed·

BSEM Financial Summary

Key Ratios

P/E Ratio8.4
Price/Book4.17
Debt / Equity9.06%
Return on Equity122.26%
Dividend Yield0.00%
EBITDA31.41M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2010
31/12
2011
31/12
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.27 / 0.51
Revenue / Forecast
72.53M / 82.50M
EPS Revisions
Last 90 days

FAQ

What were Biostem Tech's earnings for the latest quarter?

The Biostem Tech EPS (TTM) is 2.01. Biostem Tech reported sales of 72.53, net income of 4.48, and EPS of 0.27 for the latest quarter.

What was Biostem Tech's net income for the latest quarter?

Biostem Tech's net income for the latest quarter was 4.48.

How did Biostem Tech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 102.87 in the previous quarter to 72.53 in the latest quarter, and net income moved from 15.52 to 4.48 compared to the previous quarter.

What is Biostem Tech's net profit margin on a TTM basis?

Biostem Tech's trailing twelve months (TTM) net profit margin is 10.56%.

How does Biostem Tech's debt to equity ratio compare to industry standards?

Biostem Tech's total debt-to-equity ratio is 9.06%.

What is Biostem Tech's return on investment on a TTM basis?

Biostem Tech's trailing twelve months (TTM) return on investment (ROI) is 122.26%.

Did Biostem Tech gain or lose cash last quarter?

In the latest quarter, Biostem Tech's net change in cash was 3.84 million.

What were Biostem Tech's total assets and liabilities in the latest quarter?

As of the latest quarter, Biostem Tech reported total assets of 149.31 million and total liabilities of 101.49 million.

How has Biostem Tech's total revenue grown this year?

Biostem Tech's total revenue was 102.87 in the previous quarter and 72.53 in the latest quarter.

What is Biostem Tech's gross margin on a TTM basis?

Biostem Tech's trailing twelve months (TTM) gross margin is 96.28%.

What was Biostem Tech's revenue per share for the latest quarter?

Biostem Tech's revenue per share for the latest quarter was 43.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.